Colliers recently issued its Philadelphia Life Science Market Report Winter 2023, titled “Cautious Capital, Unstoppable Cures.” The report noted that Philadelphia, in a report from eConsult Solutions for the CEO Council for Growth, ranked as the second-best regional hub for cell and gene therapy growth. The same report also ranked Philadelphia fourth in human capital — in other words, talent.